EODData

MEMBERSHIP REGISTER LOG IN

FRA, ER4: Emergent BioSolutions Inc

23 Dec 2025
LAST:

10.60

CHANGE:
 0.03		OPEN:
10.76		HIGH:
10.76		ASK:
0.00		VOLUME:
200
CHG(%):
0.28		PREV:
10.57		LOW:
10.53		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
23 Dec 2510.7610.7610.5310.60200
22 Dec 2510.5710.5710.5710.57200
19 Dec 2510.5310.7010.5310.70200
18 Dec 2510.3110.3110.3110.31650
17 Dec 2510.3410.3410.3410.34650
16 Dec 2510.3310.3310.3310.33650
15 Dec 259.619.619.619.61650
12 Dec 259.909.909.909.90650
11 Dec 259.749.749.749.74650
10 Dec 259.899.899.899.89650

PROFILE

Name:Emergent BioSolutions Inc
About:Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States. The company offers NARCAN Nasal Spray for the emergency treatment of known or suspected opioid overdose; Vaxchora vaccine for the prevention of cholera; Vivotif vaccine for oral administration for the prevention of typhoid fever; Anthrasil for the treatment of inhalational anthrax; BioThrax, an anthrax vaccine; CYFENDUS for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis; and Raxibacumab injection for the treatment and prophylaxis of inhalational anthrax. It provides ACAM2000, a smallpox vaccine; CNJ-016 to address complications from smallpox vaccination; TEMBEXA for the treatment of smallpox disease caused by variola virus in adult and pediatric patients; Botulism Antitoxin Heptavalent for the treatment of symptomatic botulism; Ebanga for the treatment of Ebola; Trobigard, an atropine sulfate obidoxime chloride auto-injector. In addition, the company is developing EBS-LASV to prevent Lassa fever; EBS-MARV to prevent Marburg virus disease; EBS-SUDV to prevent Sudan virus disease; Pan-Ebola mAbs for the treatment of ebola virus; and WEVEE-VLP for equine encephalitis virus infections. Further, it provides contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, and analytical development services. The company was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.
Sector:Healthcare
Address:300 Professional Drive, Gaithersburg, MD, United States, 20879
Website:https://www.emergentbiosolutions.com
ISIN:US29089Q1058
LEI:549300YW6TUOX8BE5103

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:8.08 
Forward P/E:1.78 
PEG Ratio:-0.08 
Price to Sales:0.61 
Price to Book:0.83 
Profit Margin:0.10 
Operating Margin:0.33 
Return on Assets:0.05 
Return on Equity:0.14 
Revenue:684.69M 
EBITDA:253.77M 
Shares:53.35M 
Market Cap:565.25M 

TECHNICAL INDICATORS

MA5:10.500.9%
MA10:10.203.9%
MA20:9.976.3%
MA50:9.2015.1%
MA100:8.1829.6%
MA200:6.7157.9%
STO9:85.68 
STO14:85.68 
RSI14:68.59 
WPR14:-9.20 
MTM14:0.74
ROC14:0.08 
ATR:0.28 
Week High:10.761.6%
Week Low:10.312.8%
Month High:10.761.6%
Month Low:8.6857.9%
Year High:11.225.9%
Year Low:3.75182.8%
Volatility:69.41